Fluoxetine increases hippocampal neurogenesis and induces epigenetic factors but does not improve functional recovery after traumatic brain injury.
about
Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspironeEffects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell functionEpilepsy related to traumatic brain injury.Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents.Neurogenesis is required for behavioral recovery after injury in the visual system of Xenopus laevis.Transient postnatal fluoxetine leads to decreased brain arachidonic acid metabolism and cytochrome P450 4A in adult miceAnimal models to improve our understanding and treatment of suicidal behaviorValidity and reliability of the CatWalk system as a static and dynamic gait analysis tool for the assessment of functional nerve recovery in small animal models.Conditional overexpression of insulin-like growth factor-1 enhances hippocampal neurogenesis and restores immature neuron dendritic processes after traumatic brain injuryStudies of long-term use of antidepressants: how should the data from them be interpreted?The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis.DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls.Neuronal DNA Methylation Profiling of Blast-Related Traumatic Brain Injury.Transient postnatal fluoxetine decreases brain concentrations of 20-HETE and 15-epi-LXA4, arachidonic acid metabolites in adult mice.Models of multiple system atrophyThe need for speed in rodent locomotion analyses.Paclitaxel improves outcome from traumatic brain injury.Cognitive deficits develop 1month after diffuse brain injury and are exaggerated by microglia-associated reactivity to peripheral immune challenge.Long-term fluoxetine treatment induces input-specific LTP and LTD impairment and structural plasticity in the CA1 hippocampal subfield.Strategies targeting endogenous neurogenic cell response to improve recovery following traumatic brain injury.Catecholaminergic based therapies for functional recovery after TBIEpigenetic changes following traumatic brain injury and their implications for outcome, recovery and therapyTraumatic brain injury - modeling neuropsychiatric symptoms in rodents.Conditional ablation of neuroprogenitor cells in adult mice impedes recovery of poststroke cognitive function and reduces synaptic connectivity in the perforant pathway.Antidepressants for neuro-regeneration: from depression to Alzheimer's disease.Chronic fluoxetine ameliorates adolescent chronic nicotine exposure-induced long-term adult deficits in trace conditioning.Drugging the pain epigenome.Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics.Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder?Neuroinflammation, myelin and behavior: Temporal patterns following mild traumatic brain injury in mice.Effect of Fluoxetine on the Hippocampus of Wistar Albino Rats in Cold Restraint Stress Model.[EXPRESS] The Chemokine Receptor CXCR2 Supports Nociceptive Sensitization after Traumatic Brain Injury.Effects of Depression and Antidepressant Use on Cognitive Deficits and Functional Cognition Following Severe Traumatic Brain InjuryChronic Pain After Traumatic Brain Injury: Pathophysiology and Pain Mechanisms.Training of the impaired forelimb after traumatic brain injury enhances hippocampal neurogenesis in the Emx1 null mice lacking a corpus callosum.Chronic Treatment with Fluoxetine Induces Sex-Dependent Analgesic Effects and Modulates HDAC2 and mGlu2 Expression in Female Mice.DNA methylation in individuals with anorexia nervosa and in matched normal-eater controls: A genome-wide study.Fellutamide B Synthetic Path Intermediates with in Vitro Neuroactive Function Shows Mood-Elevating Effect in Stress-Induced Zebrafish Model
P2860
Q24633449-E7133C3E-56EF-4F1B-AA84-1CC46E7973FBQ26783101-656A8B61-3670-4A7A-A5AB-914292A445A1Q27013517-3097D668-E4A6-4E83-BDF6-E6758F445AB0Q28822571-6DB15EF7-5B1C-40ED-BAE1-6B0CC85BA3A3Q30538866-A3DF6B97-6B4C-4C53-AD25-EEEBC41B22D8Q30575789-933B8BB9-32C6-4A26-B5AF-66478246491BQ33635653-C91E7A73-2DF1-4C55-8E3B-E2D9EE6497C1Q33917360-2B24814A-323E-4F53-BBEB-F69C373A7976Q33917872-30499D94-1EDB-444F-B249-427025B508C2Q34148012-9AFF905F-6EE2-4A1D-A7F8-0F6C78778450Q34389545-52FDE6EC-442A-4969-B2EE-9D1968BD49D2Q35188064-3F0003E4-138B-4487-9D7A-3AB41F407F5CQ35941900-6E6CC1E4-4A01-454D-88DE-312E28CA5720Q36090348-CDCAE2CC-5975-4FF1-9F2B-22026C87A513Q36513407-D1741CF4-9946-4188-A344-47D0E30D5129Q36592396-FA99632A-103B-4482-8F98-36350F240AA0Q36618288-8E760DAE-7A4A-4A3C-B862-9EE32CC9ADAAQ36788625-66A4177F-7CBE-4744-8F5E-65E02C0894F9Q36828658-E60CF0DB-1540-40E3-8469-BCC6C6B6F429Q36909283-7D86EE0B-FC9E-4C10-A29E-CE47CF9A9ABFQ36909436-0037F684-E182-417C-86C6-E799D0F8242CQ37025832-E499D615-54B5-47B7-AB5B-DCCBEB020C84Q37218200-E155C92F-FC10-45CA-8AA7-537F1EF7A021Q37266487-45E3169B-20A2-40E5-8089-FD349E1F1A7DQ38152966-8278878E-B45A-41B2-9878-AC0CDDD26E2FQ38639906-E53D92F4-F368-4468-BBD7-50544ED47CC4Q38761806-6C2ADBBB-96F5-4EAE-BC05-A825B88FBA2AQ38887870-571B3C86-72FD-4F9C-91CF-159BE9BEAC88Q39405702-89B1AA0B-A1B8-487B-BE00-2AABB9704B29Q39638181-B51232D4-A545-4092-863E-5AB5B3CAB17FQ41069446-DA8B2CAE-46C5-43E6-90F1-505A266C44E5Q41176706-9026886C-E38D-46FD-9711-F4EBE1C6BFDCQ41664958-DD69833B-1FE6-4783-BA7B-D0680BAED0E2Q42587966-6FB5F7A9-1E77-44E8-A64C-A5C0F65A519CQ45992958-2CBF7AE4-6753-43C8-9D27-B54B8D4DEF1BQ46915448-220B8C68-FB15-4C69-8E79-222217DABC59Q47150462-BB188E53-44F0-44BD-8CB4-01717C0C515EQ48263402-378A5A82-8E8C-4F44-8238-20033A9D8C8EQ57489684-9ED8BA6F-F2E4-4246-ADCB-F6211A08EDC5
P2860
Fluoxetine increases hippocampal neurogenesis and induces epigenetic factors but does not improve functional recovery after traumatic brain injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fluoxetine increases hippocamp ...... after traumatic brain injury.
@en
Fluoxetine increases hippocamp ...... after traumatic brain injury.
@nl
type
label
Fluoxetine increases hippocamp ...... after traumatic brain injury.
@en
Fluoxetine increases hippocamp ...... after traumatic brain injury.
@nl
prefLabel
Fluoxetine increases hippocamp ...... after traumatic brain injury.
@en
Fluoxetine increases hippocamp ...... after traumatic brain injury.
@nl
P2093
P2860
P356
P1476
Fluoxetine increases hippocamp ...... after traumatic brain injury.
@en
P2093
Jialing Liu
Katharina Hansen
Linda J Noble-Haeusslein
Melanie Neumann
Sharon Kim
Shuwhey M Hong
Yonggang Wang
P2860
P304
P356
10.1089/NEU.2010.1648
P577
2011-02-01T00:00:00Z